CareLit · DOI-Nachweis · Pneumologie
Capmatinib (INC280) in patients (pts) with METex14-mutated advances NSCLC: an update from phase 2 GEOMETRY mono-1 study
DOI 10.1055/s-0039-3403367
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Wolf, T Seto, JY Han, N Reguart, EB Garon, HJ Groen, DSW Tan, T Hida, M de Jonge, SV Orlov, EF Smit, P Souquet, J Vansteenkiste, S Le Mouhaer, A Robeva, M Waldron-Lynch, A Balbin, L Fairchild, M Giovannini, RS Heist
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
Capmatinib (INC280) in patients (pts) with METex14-mutated advances NSCLC: an update from phase 2 GEOMETRY mono-1 study
Zitieren
Zitierempfehlung
J Wolf, T Seto, JY Han, N Reguart, EB Garon, HJ Groen, DSW Tan, T Hida, M de Jonge, SV Orlov, EF Smit, P Souquet, J Vansteenkiste, S Le Mouhaer, A Robeva, M Waldron-Lynch, A Balbin, L Fairchild, M Giovannini, RS Heist (2020) Capmatinib (INC280) in patients (pts) with METex14-mutated advances NSCLC: an update from phase 2 GEOMETRY mono-1 study. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403367
Mit CareLit weiterarbeiten